Hevert Stress Relief

Black Cohosh, Anamirta Cocculus Seed, Cypripedium Parvifolum Root, Strychnos Ignatii Seed, Lilium Lancifolium Flowering Top, Passiflora Incarnata Flowering Top, Platinum, Valerian, And Zinc Valerate Dihydrate

Hevert Arzneimittel Gmbh & Co. Kg
Human Otc Drug
NDC 54532-0010

Hevert Stress Relief also known as Black Cohosh, Anamirta Cocculus Seed, Cypripedium Parvifolum Root, Strychnos Ignatii Seed, Lilium Lancifolium Flowering Top, Passiflora Incarnata Flowering Top, Platinum, Valerian, And Zinc Valerate Dihydrate is a human otc drug labeled by 'Hevert Arzneimittel Gmbh & Co. Kg'. National Drug Code (NDC) number for Hevert Stress Relief is 54532-0010. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Hevert Stress Relief drug includes Anamirta Cocculus Seed - 6 [hp_X]/1 Black Cohosh - 4 [hp_X]/1 Cypripedium Parviflorum Var. Pubescens Root - 6 [hp_X]/1 Lilium Lancifolium Flowering Top - 6 [hp_X]/1 Passiflora Incarnata Flowering Top - 3 [hp_X]/1 Platinum - 8 [hp_X]/1 Strychnos Ignatii Seed - 6 [hp_X]/1 Valerian - 2 [hp_X]/1 Zinc Valerate Dihydrate - 4 [hp_X]/1 . The currest status of Hevert Stress Relief drug is Active.

Drug Information:

Drug NDC:	54532-0010
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Hevert Stress Relief
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Black Cohosh, Anamirta Cocculus Seed, Cypripedium Parvifolum Root, Strychnos Ignatii Seed, Lilium Lancifolium Flowering Top, Passiflora Incarnata Flowering Top, Platinum, Valerian, And Zinc Valerate Dihydrate
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Hevert Arzneimittel Gmbh & Co. Kg
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ANAMIRTA COCCULUS SEED - 6 [hp_X]/1 BLACK COHOSH - 4 [hp_X]/1 CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT - 6 [hp_X]/1 LILIUM LANCIFOLIUM FLOWERING TOP - 6 [hp_X]/1 PASSIFLORA INCARNATA FLOWERING TOP - 3 [hp_X]/1 PLATINUM - 8 [hp_X]/1 STRYCHNOS IGNATII SEED - 6 [hp_X]/1 VALERIAN - 2 [hp_X]/1 ZINC VALERATE DIHYDRATE - 4 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	15 Feb, 2013
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	10 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Hevert Arzneimittel GmbH & Co. KG
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	810258W28U K73E24S6X9 21Y9GZ1LZA 6268MFA917 CLF5YFS11O 49DFR088MY 1NM3M2487K JWF5YAW3QW MN0RX54EQA
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
54532-0010-4	10 BLISTER PACK in 1 CARTON (54532-0010-4) / 10 TABLET in 1 BLISTER PACK	15 Feb, 2013	N/A	No
54532-0010-5	2 BLISTER PACK in 1 CARTON (54532-0010-5) / 10 TABLET in 1 BLISTER PACK	15 Feb, 2013	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Hevert Stress Relief

Black Cohosh & more..

Tablet
Hevert Arzneimittel GmbH & Co. KG
NDC: 54532-0010

Purpose:

Active ingredients purpose âx" indicates a homeopathic dilution. for more information visit: www.hevertusa.com cimicifuga racemosa 4x relief of minor symptoms of tension and stress cocculus indicus 6x cypripedium pubescens 6x ignatia amara 6x lilium tigrinum 6x passiflora incarnata 3x platinum metallicum 8x valeriana officinalis 2x zincum valerianicum 4x

Product Elements:

Hevert stress relief black cohosh, anamirta cocculus seed, cypripedium parvifolum root, strychnos ignatii seed, lilium lancifolium flowering top, passiflora incarnata flowering top, platinum, valerian, and zinc valerate dihydrate black cohosh black cohosh anamirta cocculus seed anamirta cocculus seed cypripedium parviflorum var. pubescens root cypripedium parviflorum var. pubescens root strychnos ignatii seed strychnos ignatii seed lilium lancifolium flowering top lilium lancifolium flowering top passiflora incarnata flowering top passiflora incarnata flowering top platinum platinum valerian valerian zinc valerate dihydrate valeric acid lactose monohydrate magnesium stearate h

Indications and Usage:

Uses for temporary relief of minor symptoms of tension and stress, such as: restlessness mild mood changes temporary anxiety occasional sleeplessness these statements have not been evaluated by the food and drug administration. they are supported by traditional homeopathic principles.

Warnings:

Warnings do not use if you are allergic to lady's slipper or orchids. stop use and ask a doctor if symptoms persist continuously for more than 2 weeks or worsen. insomnia (sleeplessness) may be a symptom of serious underlying illness. if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away.

Do Not Use:

Dosage and Administration:

Directions adults and children over 12 years of age: dissolve 2 tablets in mouth 3 times daily. in acute cases, dissolve 2 tablets in mouth 6 times daily. children 6 to 12 years of age: dissolve 1 tablet in mouth 3 times daily. in acute cases, dissolve 1 tablet in mouth 6 times daily.

Stop Use:

Stop use and ask a doctor if symptoms persist continuously for more than 2 weeks or worsen. insomnia (sleeplessness) may be a symptom of serious underlying illness.

Package Label Principal Display Panel:

Principal display panel - 100 tablet bottle carton ndc 54532-0010-4 hevert Â® stress relief homeopathic medicine relieves symptoms of stress non habit-forming quick dissolving tablets made in germany 100 tablets hevert principal display panel - 100 tablet bottle carton

Further Questions:

Questions? 1-855-387-6466

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.